EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, GE HealthCare Technologies's enterprise value is $46,723 Mil.
GE HealthCare Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $3,513 Mil. Therefore, GE HealthCare Technologies's EV-to-EBITDA for today is 13.30.
The historical rank and industry rank for GE HealthCare Technologies's EV-to-EBITDA or its related term are showing as below:
GEHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.89 Med: 12.53 Max: 14.39
Current: 13.3
During the past 5 years, the highest EV-to-EBITDA of GE HealthCare Technologies was 14.39. The lowest was 7.89. And the median was 12.53.
GEHC's EV-to-EBITDA is ranked worse than 50.65% of 460
companies
in the Healthcare Providers & Services industry
Industry Median: 13.195
vs GEHC: 13.30
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), GE HealthCare Technologies's stock price is $86.72.
GE HealthCare Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.020. Therefore, GE HealthCare Technologies's PE Ratio for today is 28.72.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
GE HealthCare Technologies EV-to-EBITDA Historical Data
The historical data trend for GE HealthCare Technologies's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of GE HealthCare Technologies's EV-to-EBITDA
For the Health Information Services subindustry, GE HealthCare Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's EV-to-EBITDA falls into.
GE HealthCare Technologies EV-to-EBITDA Calculation
GE HealthCare Technologies's EV-to-EBITDA for today is calculated as:
GE HealthCare Technologies's current Enterprise Value is $46,723 Mil.
GE HealthCare Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,513 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (NAS:GEHC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
GE HealthCare Technologies's PE Ratio for today is calculated as:
GE HealthCare Technologies's share price for today is $86.72.
GE HealthCare Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
GE HealthCare Technologies EV-to-EBITDA Related Terms
Thank you for viewing the detailed overview of GE HealthCare Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
GE HealthCare Technologies (GE HealthCare Technologies) Business Description
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GEHC has been successfully added to your 